MNBTD
BSTC

Moody National Bank Trust Division’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Moody National Bank Trust Division’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-90
Closed -$6K – 1113
2019
Q1 		$6K Hold
90
– – ﹤0.01% 840
2018
Q4 		$5K Buy
+90
New +$5.38K ﹤0.01% 882

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Moody National Bank Trust Division's BSTC Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2019, closing a stake of 90 shares — an estimated $6K sold.

Moody National Bank Trust Division first reported a position in BSTC in Q4 2018 and held it in 2 quarters. The position peaked at $6K in Q1 2019. 114 funds tracked by Wall St. Rank hold BSTC as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining BioSpecifics Technologies Corp. position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 90 BioSpecifics Technologies Corp. shares in Q2 2019, an estimated $6K.
  • Moody National Bank Trust Division first reported a position in BioSpecifics Technologies Corp. in Q4 2018 and held it in 2 quarters.
  • Moody National Bank Trust Division's BioSpecifics Technologies Corp. position peaked at $6K in Q1 2019.
  • 114 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.